In this trial, an adenovirus carrying the TK gene (AD-hCMV-TK) and another carrying Flt3L (AD-hCMV-Flt3L) were coinjected into newly diagnosed high-grade gliomas, including GBM, followed by two 14-day courses of oral ganciclovir. This evidence concerns the gene FLT3LG and glioma.